147 related articles for article (PubMed ID: 23554930)
1. Classify hyperdiploidy status of multiple myeloma patients using gene expression profiles.
Li Y; Wang X; Zheng H; Wang C; Minvielle S; Magrangeas F; Avet-Loiseau H; Shah PK; Zhang Y; Munshi NC; Li C
PLoS One; 2013; 8(3):e58809. PubMed ID: 23554930
[TBL] [Abstract][Full Text] [Related]
2. The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
Samur MK; Shah PK; Wang X; Minvielle S; Magrangeas F; Avet-Loiseau H; Munshi NC; Li C
BMC Genomics; 2013 Oct; 14():672. PubMed ID: 24088394
[TBL] [Abstract][Full Text] [Related]
3. Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method.
Sidana S; Jevremovic D; Ketterling RP; Tandon N; Dispenzieri A; Gertz MA; Greipp PT; Baughn LB; Buadi FK; Lacy MQ; Morice W; Hanson C; Timm M; Dingli D; Hayman SR; Gonsalves WI; Kapoor P; Kyle RA; Leung N; Go RS; Lust JA; Rajkumar SV; Kumar SK
Am J Hematol; 2019 Apr; 94(4):424-430. PubMed ID: 30592078
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic classification in Korean multiple myeloma patients: prognostic significance of hyperdiploidy with 47-50 chromosomes and the number of structural abnormalities.
Lim JH; Seo EJ; Park CJ; Jang S; Chi HS; Suh C; Kim H; Kim SR
Eur J Haematol; 2014 Apr; 92(4):313-20. PubMed ID: 24372944
[TBL] [Abstract][Full Text] [Related]
5. Recurrent Cytogenetic Abnormalities in Multiple Myeloma.
Chan NC; Chan NP
Methods Mol Biol; 2017; 1541():295-302. PubMed ID: 27910031
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma.
Agnelli L; Fabris S; Bicciato S; Basso D; Baldini L; Morabito F; Verdelli D; Todoerti K; Lambertenghi-Deliliers G; Lombardi L; Neri A
Br J Haematol; 2007 Feb; 136(4):565-73. PubMed ID: 17367409
[TBL] [Abstract][Full Text] [Related]
7. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS;
Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034
[TBL] [Abstract][Full Text] [Related]
8. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.
Agnelli L; Mosca L; Fabris S; Lionetti M; Andronache A; Kwee I; Todoerti K; Verdelli D; Battaglia C; Bertoni F; Deliliers GL; Neri A
Genes Chromosomes Cancer; 2009 Jul; 48(7):603-14. PubMed ID: 19396863
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor-pathway coexpression analysis reveals cooperation between SP1 and ESR1 on dysregulating cell cycle arrest in non-hyperdiploid multiple myeloma.
Wang X; Yan Z; Fulciniti M; Li Y; Gkotzamanidou M; Amin SB; Shah PK; Zhang Y; Munshi NC; Li C
Leukemia; 2014 Apr; 28(4):894-903. PubMed ID: 23925045
[TBL] [Abstract][Full Text] [Related]
10. Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.
Sawyer JR; Tian E; Shaughnessy JD; Epstein J; Swanson CM; Stangeby C; Hale CL; Parr L; Lynn M; Sammartino G; Lukacs JL; Stein C; Bailey C; Zangari M; Davies FE; Van Rhee F; Barlogie B; Morgan GJ
Leukemia; 2017 Mar; 31(3):637-644. PubMed ID: 27694925
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of CKS1B mRNA expression and copy number gain in patients with plasma cell disorders.
Stella F; Pedrazzini E; Baialardo E; Fantl DB; Schutz N; Slavutsky I
Blood Cells Mol Dis; 2014 Sep; 53(3):110-7. PubMed ID: 24973170
[TBL] [Abstract][Full Text] [Related]
12. A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.
Chng WJ; Van Wier SA; Ahmann GJ; Winkler JM; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Oken MM; Blood E; Henderson K; Santana-Dávila R; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Greipp PR; Fonseca R
Blood; 2005 Sep; 106(6):2156-61. PubMed ID: 15920009
[TBL] [Abstract][Full Text] [Related]
13. Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.
Chng WJ; Kumar S; Vanwier S; Ahmann G; Price-Troska T; Henderson K; Chung TH; Kim S; Mulligan G; Bryant B; Carpten J; Gertz M; Rajkumar SV; Lacy M; Dispenzieri A; Kyle R; Greipp P; Bergsagel PL; Fonseca R
Cancer Res; 2007 Apr; 67(7):2982-9. PubMed ID: 17409404
[TBL] [Abstract][Full Text] [Related]
14. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma.
Wuilleme S; Robillard N; Lodé L; Magrangeas F; Beris H; Harousseau JL; Proffitt J; Minvielle S; Avet-Loiseau H;
Leukemia; 2005 Feb; 19(2):275-8. PubMed ID: 15538401
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the chronology of copy number alterations in Multiple Myeloma.
Aktas Samur A; Minvielle S; Shammas M; Fulciniti M; Magrangeas F; Richardson PG; Moreau P; Attal M; Anderson KC; Parmigiani G; Avet-Loiseau H; Munshi NC; Samur MK
Blood Cancer J; 2019 Mar; 9(4):39. PubMed ID: 30914633
[TBL] [Abstract][Full Text] [Related]
16. [Cytogenetic abnormalities in high-risk multiple myeloma].
Ishida T
Nihon Rinsho; 2015 Jan; 73(1):28-32. PubMed ID: 25626299
[TBL] [Abstract][Full Text] [Related]
17. IgH gene rearrangements are associated with hyperdiploid multiple myeloma in Korean cases: a fluorescence in situ hybridization study.
Moon HW; Cho HI; Kang SH; Kim TY; Min HC; Oh BR; Yoon SS; Lee DS
Cancer Genet Cytogenet; 2007 Jan; 172(2):172-3. PubMed ID: 17213029
[No Abstract] [Full Text] [Related]
18. Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma.
Liebisch P; Viardot A; Bassermann N; Wendl C; Roth K; Goldschmidt H; Einsele H; Straka C; Stilgenbauer S; Döhner H; Bentz M
Br J Haematol; 2003 Jul; 122(2):193-201. PubMed ID: 12846886
[TBL] [Abstract][Full Text] [Related]
19. DMG26: A Targeted Sequencing Panel for Mutation Profiling to Address Gaps in the Prognostication of Multiple Myeloma.
Cutler SD; Knopf P; Campbell CJV; Thoni A; Abou El Hassan M; Forward N; White D; Wagner J; Goudie M; Boudreau JE; Kennedy BE; Gujar S; Gaston D; Elnenaei MO
J Mol Diagn; 2021 Dec; 23(12):1699-1714. PubMed ID: 34562616
[TBL] [Abstract][Full Text] [Related]
20. Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma.
Van Wier S; Braggio E; Baker A; Ahmann G; Levy J; Carpten JD; Fonseca R
Haematologica; 2013 Oct; 98(10):1586-92. PubMed ID: 23716545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]